Lead Extraction for Treatment of Cardiac Device Infection: A 20-Year Single Centre Experience

详细信息    查看全文

• 作者：Sean Gomes ; MBBS^a ; ^{sgomes@med.usyd.edu.au} ; Gregory Cranney ; MBBS^a ; Michael Bennett ; MD^b ; Robert Giles ; MD^a
• 关键词：CIED ; Cardiac implantable electronic device ; CDI ; Cardiac device infection ; CRT ; Cardiac resynchronisation therapy ; ICD ; Internal cardioveter-defibrillator ; TLE ; Transvenous lead extraction ; PPM ; Permanent pacemaker
• 刊名：Heart, Lung and Circulation
• 出版年：2017
• 出版时间：March 2017
• 年：2017
• 卷：26
• 期：3
• 页码：240-245
• 全文大小：344 K
• 卷排序：26

文摘

Infection is one of the most feared complications of cardiac implantable electronic devices. We report microbiology, antimicrobial therapy and infection recurrence in patients with cardiac device infection (CDI) treated with transvenous lead extraction (TLE) at a single centre over a 20-year period.MethodsWe identified a cohort of consecutive patients undergoing TLE for CDI by a single operator at a single high volume centre. Retrospective analysis of patient characteristics, microbiology, outcomes and infection recurrence was performed.ResultsBetween May 1992 to March 2012, 348 patients underwent extraction due to localised or systemic infection. Seven hundred and twenty leads were extracted from these patients. The mean follow-up was 5.5+/-4.9 years. Staphylococcal species accounted for 81% of CDI. A difference is seen in infection onset for device revision compared with initial implants [median 10 months vs 24 months, P = 0.0001]. Duration of antibiotics therapy depended on the nature of the CDI (21 days post TLE for systemic vs. 10 days for localised infection, P < 0.0001). There was comparable mortality in the 37 (11.2%) patients who did not have a replacement device compared with a replacement (30% vs 29%, P = 0.9). Retained lead fragments are a risk factor for CDI recurrence (20.8% recurrence in retained fragments vs 4.3% in complete removal, P = 0.006).ConclusionCardiac device infection can be successfully treated with a combination of TLE and antibiotic therapy. Device therapy can be safely withdrawn in some patients. Retained lead fragments are a risk factor for recurrent CDI following extraction.